Carvedilol Does Not Improve Exercise Performance in Fontan Patients: Results of a Crossover Trial

Volume: 42, Issue: 4, Pages: 934 - 941
Published: Feb 14, 2021
Abstract
Increased circulating catecholamines are associated with worse exercise performance in adult heart failure patients. Patients with Fontan physiology have increased circulating catecholamines and theoretically could benefit from beta blockade. We hypothesized that carvedilol would improve exercise performance in Fontan patients. A double-blind, placebo-controlled, crossover trial of carvedilol was performed. Single ventricle patients between the...
Paper Details
Title
Carvedilol Does Not Improve Exercise Performance in Fontan Patients: Results of a Crossover Trial
Published Date
Feb 14, 2021
Volume
42
Issue
4
Pages
934 - 941
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.